ResultsBusiness Standard
Entero Healthcare shares zoom 33% on strong Q2 results
Positive+46
GreyOak summary
Entero Healthcare shares rose 33% in a week, hitting a new high of ₹2,095.30. The company reported 33% revenue growth and 66% profit growth for Q2FY27. Management anticipates surpassing the 23% FY27 revenue guidance, driven by organic growth and MedTech contributions.
What it affects
- Entero Healthcare SolutionsENTEROPositive +46
Stock surged 33% on strong Q2 results.Rolling sentiment Positive +43
Source
Read the original at Business StandardMore Entero Healthcare Solutions news
- ICICI Securities maintains Buy rating on Entero with Rs 2100 targetMoneycontrol · Company update ·